Pharma, Pride and the LGBTQ+ community - European Medical Journal

Pharma, Pride and the LGBTQ+ community

EMJ GOLD
Series 5: episode 4

This week, as we approach the end of Pride Month, the GOLD team looks into how the industry can proactively support patients and staff who are part of the LGBTQ+ community.

Join Isabel and Jade as they look at how the industry can avoid ‘rainbow washing’ and tokenism to drive a positive change both inside and outside their organisations. This will include highlighting effective initiatives from BMS, GSK, Genentech and Pfizer, who like many others, are committed to supporting the community during Pride Month and beyond.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given